Compositions and methods for analyte detection

US2023212657A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2023212657-A1
Application numberUS-202217875211-A
CountryUS
Kind codeA1
Filing dateJul 27, 2022
Priority dateJan 29, 2020
Publication dateJul 6, 2023
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure provides methods, systems and compositions for detecting nucleic acid sequences in a biological sample having a three-dimensional matrix. The present disclosure also provides methods, systems and compositions for processing a biological sample for use in nucleic acid sequence detection

First claim

Opening claim text (preview).

1 .- 149 . (canceled) 150 . A method for processing a biological sample, comprising: (a) providing said biological sample comprising a polypeptide analyte within a synthetic three-dimensional (3D) matrix, which synthetic 3D matrix comprises an attachment moiety; (b) contacting said biological sample with a tethering molecule, wherein said tethering molecule comprises (i) an antibody or fragment thereof conjugated to a nucleic acid barcode and (ii) a tethering moiety; and (c) binding said polypeptide analyte with said tethering molecule; thereby attaching said analyte to said synthetic 3D matrix via said attachment moiety. 151 . The method of claim 150 , wherein said synthetic 3D matrix comprises an additional attachment moiety. 152 . The method of claim 150 , wherein (b) is performed simultaneously with forming of the synthetic 3D matrix. 153 . The method of claim 150 , wherein (b) is performed after forming of the synthetic 3D matrix. 154 . The method of claim 150 , wherein, in (a), said biological sample comprises an additional analyte within said synthetic 3D matrix. 155 . The method of claim 151 , wherein said additional analyte is a nucleic acid molecule. 156 . The method of claim 155 , further comprising providing an additional tethering molecule, wherein said additional tethering molecule comprises a primer sequence complementary to a sequence of said nucleic acid molecule. 157 . The method of claim 156 , further comprising, hybridizing said primer sequence to said sequence of said nucleic acid molecule. 158 . The method of claim 157 , further comprising, extending said primer sequence hybridized to said sequence of said nucleic acid molecule to generate an extension product. 159 . The method of claim 158 , wherein said extension product is attached to said synthetic 3D matrix. 160 . The method of claim 158 , further comprising hybridizing a probe to said extension product. 161 . The method of claim 161 , wherein said probe is a padlock probe or a molecular inversion probe. 162 . The method of claim 160 , further comprising circularizing said probe. 163 . The method of claim 162 , wherein said circularizing comprises ligating a 3′ end and a 5′ end of said probe. 164 . The method of claim 160 , further comprising subjecting said probe to an amplification reaction to generate an amplification product. 165 . The method of claim 164 , wherein said amplification reaction is rolling circle amplification. 166 . The method of claim 164 , wherein said amplification reaction incorporates a modified base to said amplification product. 167 . The method of claim 166 , wherein said modified base is 5-azidomethyl-dUTP. 168 . The method of claim 151 , wherein said attachment moiety and said additional attachment moiety are different. 169 . The method of claim 156 , wherein said additional tethering molecule (i) flows through said synthetic 3D matrix and comes in contact with said additional analyte, and (ii) attaches to said additional analyte and said additional attachment moiety, thereby attaching said additional analyte to said synthetic 3D matrix.

Assignees

Inventors

Classifications

  • C12Q1/6841Primary

    In situ hybridisation · CPC title

  • Methods for sequencing · CPC title

  • Nucleic acid analysis using immunogens (immunoassay G01N33/53) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2023212657A1 cover?
The present disclosure provides methods, systems and compositions for detecting nucleic acid sequences in a biological sample having a three-dimensional matrix. The present disclosure also provides methods, systems and compositions for processing a biological sample for use in nucleic acid sequence detection
Who is the assignee on this patent?
10X Genomics Inc
What technology area does this patent fall under?
Primary CPC classification C12Q1/6841. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Jul 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).